Catalio Capital Management logo

Catalio Capital Management

Investments
91
Lead Investments
22

Catalio Capital Management is a multi-strategy investment firm focused on investing in breakthrough biomedical technology and innovative healthcare companies worldwide. Founded by George Petrocheilos and Dr. Jacob Vogelstein, the firm aims to leverage the expertise of world-renowned scientist-entrepreneurs to drive innovation in the biomedical sector.

Founded 2016
North America, United States
11-50
cataliocapital.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Therapeutics
Medical
Life Science

Investment Types

Debt
Early Stage Venture
Late Stage Venture

Notable Investments

Parabilis Medicines logo
Freenome logo
Recursion Pharmaceuticals logo
Recursion logo
Aviceda Therapeutics logo
DNA Script logo
Alentis Therapeutics logo
Affini-T Therapeutics logo
Avalyn Pharma logo
Odyssey Therapeutics logo
ATAI Life Sciences logo
ArriVent Biopharma logo
Clasp Therapeutics logo
InSightec logo
Imperative Care logo

Investment History

Team